Results 161 to 170 of about 21,695 (218)

Drug-Eluting Balloon Therapy for In-Stent Restenosis of Drug-Eluting Stents

JACC: Cardiovascular Interventions, 2018
Brigitta C. Brott, Arka Chatterjee
openaire   +1 more source

A randomized controlled trial comparing the efficacy and safety of indobufen versus aspirin in reducing target vessel restenosis after drug-eluting balloon angioplasty in patients with coronary artery disease. [PDF]

Clinics (Sao Paulo)
Jiang Z, Zhu D, Meng J.
europepmc   +1 more source

Drug-eluting balloon to treat immediate post-coronary artery bypass grafting ST-elevation myocardial infarction: a case report. [PDF]

Eur Heart J Case Rep
Shah MU, Haider MA, Poudyal K, Loubani M, Naqvi SY.   +4 more
europepmc   +1 more source

Stentless treatment strategy for left circumflex artery ostial stenosis: Directional coronary atherectomy followed by drug-eluting balloon. [PDF]

J Cardiol Cases, 2020
Hirohata A, Shiomi T, Yoshioka R.
europepmc   +1 more source

[Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis]. [PDF]

REC Interv Cardiol
Padilla L, Liberman F, Tello J, Rosas P, Spaletra P, Pedernera G, Mascolo P, Ordoñez S, Santilli P, Candiello A, Cura F, Belardi J, Lamelas P.   +12 more
europepmc   +1 more source

Single-center outcomes of Onyx Frontier™ and Resolute Onyx™ drug-eluting balloon-mounted stents for rescue stenting for acute large vessel occlusion. [PDF]

Interv Neuroradiol
Mehta SH, White TG, Shah KA, Lynch DG, Werner CD, Teron I, Link T, Patsalides A, Woo HH.   +8 more
europepmc   +1 more source

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis. [PDF]

J Interv Cardiol, 2020
Yang YX, Liu Y, Li CP, Lu PJ, Wang J, Gao J.   +5 more
europepmc   +1 more source

Angiologie: drug-eluting balloon: stents bientôt superflus?

Forum Médical Suisse ‒ Swiss Medical Forum, 2010
H Stricker, BR AmannVesti
openaire   +1 more source

Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807. [PDF]

J Clin Med
van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, Henriques JPS, Claessen BEPM.   +11 more
europepmc   +1 more source